Enrofloxacin resistance in Escherichia coli isolated from dogs with urinary tract infections

Journal of the American Veterinary Medical Association

Volumn 220, Issue 2, 2002, Pages 190-192

  Cooke, Cara L ^a,b   Singer, Randall S ^b   Jang, Spencer S ^a   Hirsh, Dwight C ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; ANTIBIOTIC AGENT; BACTERIAL DNA; CEFALEXIN; CHLORAMPHENICOL; COTRIMOXAZOLE; TETRACYCLINE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATION; DISEASE ASSOCIATION; DNA DETERMINATION; DOG; ESCHERICHIA COLI; GEOGRAPHIC DISTRIBUTION; NONHUMAN; PULSED FIELD GEL ELECTROPHORESIS; STRAIN DIFFERENCE; UNITED STATES; URINALYSIS; URINARY TRACT INFECTION; VETERINARY MEDICINE;

BACTERIA (MICROORGANISMS); CANIS FAMILIARIS; ESCHERICHIA COLI;

EID: 0037080164     PISSN: 00031488     EISSN: None     Source Type: Journal    
DOI: 10.2460/javma.2002.220.190     Document Type: Article

References (13)

1. Plumb DC. Veterinary drug handbook. Ames, Iowa: Iowa State University Press, 1999;238-241.
2. Brown JC, Amyes SGB. Quinolone resistance. In: Woodford N, Johnson AP, eds. Molecular bacteriology. Totowa, NJ: Humana Press, 1998;617-639.
3. Nakamura S, Nakamura M, Kojima T, et al. gyrA and gyrB mutations in quinolone-resistant strains of Escherichia coli. Antimicrob Agents Chemother 1989;33:254-255.
4. Park YH, Yoo JH, Huh DH, et al. Molecular analysis of fluoroquinolone-resistance in Escherichia cali on the aspect of gyrase and multiple antibiotic resistance (mar) genes. Yonsei Med 1998;39:534-540.
5. Tavio M, Vila J, Ruiz J, et al. Mechanisms involved in the development of resistance to fluoroquinolones in Escherichia cali isolates. J Antimicrob Chemother 1999;44:735-742.
6. Vila J, Ruiz J, Goni P, et al. Detection of mutations in parC in quinolone-resistant clinical isolates of Escherichia coli. Antimicrob Agents Chemother 1996;40:491-493.
7. Hooper DC, Wolfson JS, Souza KS, et al. Mechanisms of quinolone resistance in Escherichia coli: characterization of nfxB and cfxB, two mutant resistance loci decreasing norfloxacin accumulation. Antimicrob Agents Chemother 1989;33:283-290.
8. Linde HJ, Notka F, Metz M, et al. In vivo increase in resistance to ciprofloxacin in Escherichia coli associated with deletion of the C-terminal part of MarR. Antimicrob Agents Chemother 2000;44:1965-1868.
9. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial disk and dilution susceptibility tests for bacteria isolated from animals; approved standard. Document M31-A. Wayne, Pa: National Committee for Clinical Laboratory Standards, 1999;34-48.
10. Woods GL, Washington JA. Antibacterial susceptibility tests: dilution and disk diffusion methods. In: Murray PR, ed. Manual of clinical microbiology. 6th ed. Washington, DC: American Society for Microbiology Press, 1995;1327-1341.
11. Dice LR. Measures of the amount of ecological association between species. Ecology 1945;26:297-392.
12. Gaynes R, Monnet D. The contribution of antibiotic use on the frequency of antibiotic resistance in hospitals. Ciba found Symp 1997;207:47-56.
13. Ena J, Lopez-Perezagua MM, Martinez-Peinado C, et al. Emergence of ciprofloxacin resistance in Escherichia coli isolates alter widespread use of fluoroquinolones. Diagn Microbiol Infect Dis 1998;30:103-107.